244 related articles for article (PubMed ID: 32585603)
1. The effect of olmesartan on aortic intimal thickening after balloon injury through Apelin/APJ.
Li Y; Guo J; Yu H; Zhou J; Chu X; Hou B; Ge J; Li T; Duan S; Xu H; Yang X
Cardiovasc Pathol; 2020; 49():107230. PubMed ID: 32585603
[TBL] [Abstract][Full Text] [Related]
2. [Effects of valsartan on aortic angiotensin converting enzyme 2 expression after aortic balloon injury in rats].
Li YH; An Y; Wang QX; Man YL; Liu P; Ren BB
Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Aug; 40(8):697-701. PubMed ID: 23141017
[TBL] [Abstract][Full Text] [Related]
3. Valsartan Prevented Neointimal Hyperplasia and Inhibited SRSF1 Expression and the TLR4-iNOS-ERK-AT1 Receptor Pathway in the Balloon-injured Rat Aorta.
Li Y; Guo J; Yu H; Liu X; Zhou J; Chu X; Xu Q; Sun T; Peng L; Yang X; Tang X
Physiol Res; 2021 Aug; 70(4):533-542. PubMed ID: 34062069
[TBL] [Abstract][Full Text] [Related]
4. Effects of rosuvastatin on expression of angiotensin-converting enzyme 2 after vascular balloon injury in rats.
Li YH; Wang QX; Zhou JW; Chu XM; Man YL; Liu P; Ren BB; Sun TR; An Y
J Geriatr Cardiol; 2013 Jun; 10(2):151-8. PubMed ID: 23888175
[TBL] [Abstract][Full Text] [Related]
5. Effects of olmesartan on Apelin/APJ and Akt/endothelial nitric oxide synthase pathway in Dahl rats with end-stage heart failure.
Fukushima H; Kobayashi N; Takeshima H; Koguchi W; Ishimitsu T
J Cardiovasc Pharmacol; 2010 Jan; 55(1):83-8. PubMed ID: 19904215
[TBL] [Abstract][Full Text] [Related]
6. Valsartan decreases neointimal hyperplasia in balloon-injured rat aortic arteries by upregulating HO-1 and inhibiting angiotensin II type 1 receptor.
Li Y; Wang Q; Xu Q; Cai S; Zhou J; Ren B; Sun T; Liu X; Yu H
Life Sci; 2014 Aug; 110(2):70-6. PubMed ID: 25014676
[TBL] [Abstract][Full Text] [Related]
7. The counterregulating role of ACE2 and ACE2-mediated angiotensin 1-7 signaling against angiotensin II stimulation in vascular cells.
Hayashi N; Yamamoto K; Ohishi M; Tatara Y; Takeya Y; Shiota A; Oguro R; Iwamoto Y; Takeda M; Rakugi H
Hypertens Res; 2010 Nov; 33(11):1182-5. PubMed ID: 20703229
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of angiotensin converting enzyme 2 in conjunction with reduction of neointima by angiotensin II type 1 receptor blockade.
Igase M; Kohara K; Nagai T; Miki T; Ferrario CM
Hypertens Res; 2008 Mar; 31(3):553-9. PubMed ID: 18497476
[TBL] [Abstract][Full Text] [Related]
9. Reduction of In-Stent Restenosis by Cholesteryl Ester Transfer Protein Inhibition.
Wu BJ; Li Y; Ong KL; Sun Y; Shrestha S; Hou L; Johns D; Barter PJ; Rye KA
Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2333-2341. PubMed ID: 29025709
[TBL] [Abstract][Full Text] [Related]
10. Regulation of apelin and its receptor expression in adipose tissues of obesity rats with hypertension and cultured 3T3-L1 adipocytes.
Wu H; Cheng XW; Hao C; Zhang Z; Yao H; Murohara T; Dai Q
Exp Anim; 2014; 63(2):257-67. PubMed ID: 24770651
[TBL] [Abstract][Full Text] [Related]
11. RhoGDI stability is regulated by SUMOylation and ubiquitination via the AT1 receptor and participates in Ang II-induced smooth muscle proliferation and vascular remodeling.
Dai F; Qi Y; Guan W; Meng G; Liu Z; Zhang T; Yao W
Atherosclerosis; 2019 Sep; 288():124-136. PubMed ID: 31362179
[TBL] [Abstract][Full Text] [Related]
12. The angiotensin II receptor antagonist, losartan, enhances regulator of G protein signaling 2 mRNA expression in vascular smooth muscle cells of Wistar rats.
Wu Y; Nakagawa S; Takahashi H; Kawabata Y; Suzuki E; Uehara Y
Hypertens Res; 2016 May; 39(5):295-301. PubMed ID: 26763849
[TBL] [Abstract][Full Text] [Related]
13. Human urine kininogenase attenuates balloon-induced intimal hyperplasia in rabbit carotid artery through transforming growth factor β1/Smad2/3 signaling pathway.
Lan W; Yang F; Li Z; Liu L; Sang H; Jiang Y; Xiong Y; Zhang R
J Vasc Surg; 2016 Oct; 64(4):1074-83. PubMed ID: 26054589
[TBL] [Abstract][Full Text] [Related]
14. Suv39h1 downregulation inhibits neointimal hyperplasia after vascular injury.
Zhang J; Chen J; Yang J; Xu C; Hu Q; Wu H; Cai W; Guo Q; Gao W; He C; Yang C; Yang J
Atherosclerosis; 2019 Sep; 288():76-84. PubMed ID: 31330382
[TBL] [Abstract][Full Text] [Related]
15. Role of angiotensin II type-1 and type-2 receptors on vascular smooth muscle cell growth and glucose metabolism in diabetic rats.
Igarashi M; Hirata A; Nozaki H; Kadomoto-Antsuki Y; Tominaga M
Diabetes Res Clin Pract; 2007 Mar; 75(3):267-77. PubMed ID: 16934905
[TBL] [Abstract][Full Text] [Related]
16. The apelin/APJ system in the regulation of vascular tone: friend or foe?
Rikitake Y
J Biochem; 2021 Apr; 169(4):383-386. PubMed ID: 33169143
[TBL] [Abstract][Full Text] [Related]
17. Apelin/APJ system: A critical regulator of vascular smooth muscle cell.
Luo X; Liu J; Zhou H; Chen L
J Cell Physiol; 2018 Jul; 233(7):5180-5188. PubMed ID: 29215755
[TBL] [Abstract][Full Text] [Related]
18. Valsartan ameliorates ageing-induced aorta degeneration via angiotensin II type 1 receptor-mediated ERK activity.
Shan H; Zhang S; Li X; Yu K; Zhao X; Chen X; Jin B; Bai X
J Cell Mol Med; 2014 Jun; 18(6):1071-80. PubMed ID: 24548645
[TBL] [Abstract][Full Text] [Related]
19. Losartan, a nonpeptide angiotensin II (Ang II) receptor antagonist, inhibits neointima formation following balloon injury to rat carotid arteries.
Kauffman RF; Bean JS; Zimmerman KM; Brown RF; Steinberg MI
Life Sci; 1991; 49(25):PL223-8. PubMed ID: 1745100
[TBL] [Abstract][Full Text] [Related]
20. Impaired regulator of G protein signaling 2 transcription facilitates vascular remodeling in injured rat aorta.
Mao Y; Su J; Lei L; Meng L; Qi Y; Huo Y; Tang C
J Cardiovasc Med (Hagerstown); 2014 Jul; 15(7):572-8. PubMed ID: 24914635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
